HL7 Terminology (THO)
3.0.0 - Publication

This page is part of the HL7 Terminology (v3.0.0: Release) based on FHIR R4. The current version which supercedes this version is 5.2.0. For a full list of available versions, see the Directory of published versions

ValueSet: SpecimenAdditiveEntity

Summary

Defining URL:http://terminology.hl7.org/ValueSet/v3-SpecimenAdditiveEntity
Version:2.0.0
Name:SpecimenAdditiveEntity
Status:Active as of 3/26/14
Definition:

Set of codes related to specimen additives

OID:2.16.840.1.113883.1.11.16042 (for OID based terminology systems)
Source Resource:XML / JSON / Turtle

References

Logical Definition (CLD)

This value set includes codes based on the following rules:

This value set excludes codes based on the following rules:

 

Expansion

This value set contains 54 concepts

Expansion based on EntityCode v2.0.0 (CodeSystem)

All codes in this table are from the system http://terminology.hl7.org/CodeSystem/v3-EntityCode

CodeDisplayDefinition
ACDAACD Solution AACD Solution A of trisodium citrate, 22.0g/L; citric acid, 8.0 g/L; and dextrose 24.5 g/L. Used in Blood banking and histocompatibilty testing
ACDBACD Solution BACD Solution B of trisodium citrate, 13.2g/L; citric acid, 4.8 g/L; and dextrose 14.7 g/L. Used in Blood banking and histocompatibilty testing.
ACETAcetic Acid50% V/V acetic acid in water. Used as a urine preservative
AMIESAmies transport mediumSodium Chloride 3.0g, Potassium Chloride 0.2g, Calcium Chloride 0.1g, Magnesium Chloride 0.1g, Monopotassium Phosphate 0.2g, Disodium Phosphate 1.15g, Sodium Thiogly collate 1.0g, Distilled Water 1 liter
BACTMBacterial Transport mediumAny medium used to maintain bacterial viability (e.g. Stuart's, Cary-Blair, Amies)
BF10Buffered 10% formalinFormaldehyde 4% w/v; methyl alcohol 1% w/v; phosphate buffering salts. Tissue preservative
BORBoric AcidPowdered boric acid (usually 10 g) added to 24-hour urine collections as a preservative.
BOUINBouin's solutionPicric acid, saturated aqueous solution (750.0 ml), 37-40% formalin (250.0 ml), glacial acetic acid (50.0 ml). Tissue preservative.
BSKMBuffered skim milk50% skim milk in 0.01 M phosphate-buffered saline. Maintain virus viability
C323.2% CitrateA 3.2% solution of Sodium Citrate in water. Used as a blood preservative
C383.8% CitrateA 3.8% solution of Sodium Citrate in water. Used as a blood preservative
CARSCarson's Modified 10% formalinA modification of buffered 10% formalin used as a general tissue preservative.
CARYCary Blair MediumSodium Thioglycollate 1.5 g, Disodium Hydrogen Phosphate 1.1 g, Sodium Chloride 5.0 g, Calcium Chloride 0.09 g, Agar 5.0 g, per Liter of Water
CHLTMChlamydia transport mediumAny of a number of non-nutritive buffered media used to maintain Chlamydia viability during transportation to the laboratory
CTADCTADBuffered tri-sodium citrate solution with theophylline, adenosine and dipyridamole
EDTK15Potassium/K EDTA 15%Potassium EDTA 15% solution in water
EDTK75Potassium/K EDTA 7.5%Potassium EDTA 7.5% solution in water
EDTNSodium/Na EDTASodium fluoride and Disodium EDTA
ENTEnteric bacteria transport mediumAny of a number of non-nutritive buffered media used to maintain enteric bacterial viability during transportation to the laboratory
F1010% FormalinA 10% v/v solution in water of formalin( a 37% solution of formaldehyde and water). Used for tissue preservation.
FDPThrombin NIH; soybean trypsin inhibitorThrombin plus soybean trypsin inhibitor. For use in identifying fibrn degredation products.
FL10Sodium Fluoride, 10mgSodium fluoride, 10mg added as a urine preservative.
FL100Sodium Fluoride, 100mgSodium fluoride, 100mg added as a urine preservative.
HCL66N HCLA solution of HCl containing 6moles of hydrogen ion/L. Used as a Urine Preservative.
HEPAAmmonium heparinAmmonium heparin
HEPLLithium/Li HeparinLithium heparin salt
HEPNSodium/Na HeparinSodium heparin salt
HNO3Nitric Acid6N Nitric acid used to preserve urine for heavy metal analysis.
JKMJones Kendrick MediumA transport medium formulated to maintain Bordetella pertussis viability.
KARNKarnovsky's fixative5% Glutaraldehyde, 4% Formaldehyde in 0.08M buffer. Tissue preservation
KOXPotassium OxalatePotassium oxalate and sodium fluoride in a 1.25:1 ratio
LIALithium iodoacetateIodoacetate lithium salt
M4M4Modified Hank's balanced salt solution supplemented with bovine serum albumin, gelatin, sucrose and glutamic acid. It is buffered to pH 7.3+ or - 0.2 with HEPES buffer. Phenol red is used to indicate pH. Vancomycin, Amphotericin B and Colistin are used to
M4RTM4-RTModified Hank's balanced salt solution supplemented with bovine serum albumin, gelatin, sucrose and glutamic acid. It is buffered to pH 7.3+ or - 0.2 with Hepes buffer. Phenol red is used to indicate pH. Gentamicin and amphotericin B are used to inhibit c
M5M5Modified Hank's balanced salt solution supplemented with protein stabilizers, sucrose and glutamic acid. It is buffered to pH 7.3+ or - 0.2 with Hepes buffer. Phenol red is used to indicate pH. Vancomycin, Amphotericin B and Colistin are used to inhibit c
MICHTMMichel's transport medium1M potassium citrate, pH 7.0 2.5 ml, 0.1M magnesium sulfate 5.0 ml, 0.1M N-ethyl malemide 5.0 ml, dH2O 87.5 ml, ammonium sulfate 55gm. Preserve antigens for Immunofluorescence procedures
MMDTMMMD transport mediumA buffered medium with ammonium sulfate added to preserve antigens for Immunofluorescence procedures
NAFSodium FluorideSodium fluoride
NONENoneNo additive. Specifically identifes the specimen as having no additives.
PAGEPage's Saline0.12 g NaCl, 0.004 g MgSO, 0.004 g, CaCl, 0.142 g Na2HPO4 and 0.136 g KH2PO4 per liter of distilled water. Maintain Acanthaoemba viability.
PHENOLPhenolPhenol. Urine preservative
PVAPolyvinylalcoholPolyvinyl alcohol
RLMReagan Lowe MediumA transport medium formulated to maintain Bordetella pertussis viability.
SILICASiliceous earthDiatomaceous earth. For glucose determination blood samples
SPSSodium polyanethol sulfonate 0.35% in 0.85% sodium chlorideSodium polyanethol sulfonate in saline. Anticomplementary and antiphagocytic properties. Used in blood culture collection.
SSTSerum Separator TubePolymer separator gel with clot activator
STUTMStuart transport mediumSodium Glycerophosphate 10.0g, Calcium Chloride 0.1g, Mercaptoacetic Acid 1.0ml, Distilled Water 1 liter
THROMThrombinThrombin. Accelerates clotting.
THYMOLThymol2-Isopropyl-5-methyl phenol. A preservative for 24 Hr Urine samples
THYOThyoglycolate brothA nutritive medium with a reducing agent (sodium thioglycolate) which, due to a chemical reaction, removes oxygen from the broth.
TOLUTolueneAlso known as Methylbenzene; Toluol; Phenylmethane. A preservative for 24 Hr Urine samples
URETMUreaplasma transport mediumA buffered salt solution with antifungal agents added for the collection and transport of Ureaplasma specimens.
VIRTMViral Transport mediumSucrose 74.6g, Potassium hydrogenphosphate 0.52g, L-glutamic acid 0.72g, Bovine serum albumin 5.0g, Gentamicin 50mg, Potassium dihydrogenphosphate 1.25g, L-15 medium 9.9L, Water to 10L. Maintain Virus viability.
WESTBuffered Citrate3.8% Citrate buffered to a pH of 5.5 for Westergren Sedimentation Rate

Explanation of the columns that may appear on this page:

Level A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies
Source The source of the definition of the code (when the value set draws in codes defined elsewhere)
Code The code (used as the code in the resource instance)
Display The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application
Definition An explanation of the meaning of the concept
Comments Additional notes about how to use the code

History

DateActionCustodianAuthorComment
2020-05-06reviseVocabulary WGTed KleinMigrated to the UTG maintenance environment and publishing tooling.
2014-03-26revise2014T1_2014-03-26_001283 (RIM release ID)Vocabulary (Woody Beeler) (no record of original request)Lock all vaue sets untouched since 2014-03-26 to trackingId 2014T1_2014_03_26